| Name | Title | Contact Details |
|---|
North Plains Systems Inc. is a Toronto, ON-based company in the Software and Internet sector.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Real Intent is the EDA leader for intent driven static sign-off, accelerating the early functional verification and advanced sign-off of digital designs.
HatchWorks is a software design and development company that helps technology leaders modernize and accelerate their business critical technology projects by creating software solutions people love.